J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says
June 17, 2026
12,410
9
3
0.10%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
David Rubenstein Episodes Around June 17, 2026
See what was published immediately before and after this episode.
3:38Now PlayingJ&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says
YouTube Description
as posted by the channelJohnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo Nordisk.
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
Learn more about David:
Connect with us on...
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.